NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Secondary Hyperparathyroidism
Date of first enrollment	10/07/2008
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : ABT-358|Paricalcitol INN of investigational material : Paricalcitol Therapeutic category code : 311 Vitamin A, D and preparations Dosage and Administration for Investigational material : IV (administered through intravenous-catheter of the dialysis)

Outcome(s)

Primary Outcome	The proportion of subjects with iPTH measurement =<180 pg/mL at the final visit, etc.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Both
Include criteria	Aged 20 or over Subjects allocated to paricalcitol groups in the phase IIb study (dose-response study) and completed it with good tolerability to paricalcitol injection
Exclude criteria